NCT06976502
Health eHeart BioBank
Enrolling by Invitation
Not specifiedAges 18+ObservationalUniversity of California, San FranciscoInvestigator-initiated
~500,000 participants
Updated 2026-07-14 on ClinicalTrials.gov
What's tested:Blood DrawTissue CollectionDNA CollectionMedical Chart Review
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Establish and Maintain a Centralized Biorepository
Measured over Up to 10 years
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Jeffrey E Olgin, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
- Gregory Marcus, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
- Vasanth Vedantham, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
- Connor G O'Brien, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
- James P Pirruccello, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age ≥ 18 years or older.
Established patient seen at UCSF and/or is a current participant in a clinical study that utilizes the HeH BioBank for biospecimen collection.
Family member of a patient with cardiovascular disease.
Patient with no cardiovascular disease.
Exclusion
Unwilling to consent to biospecimen collection through the HeH BioBank.
What this trial measures
- Establish and Maintain a Centralized BiorepositoryUp to 10 years
Establish and maintain a centralized biorepository to collect and store a variety of biospecimen samples and clinical data. This would allow for the samples and clinical data to be used to test hypotheses regarding the molecular and genetic basis of diagnosis and treatment of cardiovascular diseases.